| Net Cash Provided by (Used in) Operating Activities |
$8,200 |
USD |
-12% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$8,200 |
USD |
12% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
242,669,234 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q3 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q2 2025 |
Q1 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.5 |
pure |
138% |
Q2 2025 |
Q1 2026 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Additional Paid in Capital |
$1,156,638 |
USD |
0.05% |
Q3 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$254,000 |
USD |
2.4% |
Q3 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2025 |